CAREN logo

You are here

  1. Home
  2. 131IDose assessment

131IDose assessment

Radiation safety assessment of caregivers of thyroid cancer patients treated with 131I in Taiwan

Released thyroid cancer patients treated with 131I may cause a radiation risk to their family members. However, no current regulations exist in Taiwan to limit the radiation dose among patients released post-treatment. This study assessed radiation exposure to caregivers of thyroid cancer patients treated with 131I to verify whether their doses exceed the 5-mSv limit per treatment session. The study population comprised 63 patients from four hospitals and their caregivers. Dose rates at a 1-m distance from patients were quantified before their release.

Mon, 07/13/2020 - 13:23